Skip to content

Effect of gait training with Digital Treadmill system on gait and balance function in patients with cerebral small vessel disease

Effect of gait training with Digital Treadmill system on gait and balance function in patients with cerebral small vessel disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020537
Enrollment
Unknown
Registered
2019-01-07
Start date
2019-01-20
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral small vessel disease

Interventions

Group 1:Digital treadmill gait training + Traditional gait training
Control group:Traditional gait training

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged 45-75 years old; 2. all patients underwent 3.0 MRI, the image is clear, MRI manifested as m agnetic resonance imaging (MRI), T2 weighted imaging and fluid attenuated inversion recovery , FLAIR) upper white matter high signal, Fazekas score = 2 or at least one lacunar infarct; 3. agreed to systematic cognitive and motor function evaluation; 4. can complete 3D gait analysis, Pro-Kin balance assessment, MMSE scale and Montreal Assessment Scale (MoCA), berg balance scale, Tinetti scale, Barthel index scale, Morse fall assessment scale; 5. Tinetti score <24; 6. lower limb muscle strength = 3; 7. blood pressure stability (100-160/60-100mmHg); 8. patients can understand the therapist or instrument instructions, and can complete the required actions; 9. agree to participate in the study, sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cognitive impairment: MoCA score <10 points; 2. There are uncorrectable vision, hearing impairment or other reasons, can not cooperate with the examiner, including those who can not undergo magnetic resonance examination; 3. possible cardiac embolism and aortic sclerosing cerebral infarction; 4. other abnormalities caused by gait, such as Spinal cord injury, peripheral neuropathy, infectious central nervous system disease, osteoarthrosis, etc.; 5. There are neurodegenerative or degenerative diseases such as Parkinson's disease and other neurological diseases that may affect cognition; 6. other causes of white matter high signal, such as multiple sclerosis, metabolic or toxic encephalopathy, infection, etc.; 7. have serious bone and joint disease, affecting the active.

Design outcomes

Primary

MeasureTime frame
gait length;

Countries

China

Contacts

Public ContactHong You

Gansu Provincial Hospital

1491175385@qq.com+86 0931-8281455

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026